The effect of proteasome inhibition on p53 degradation and proliferation in tonsil epithelial cells

被引:5
|
作者
Harris, George F. [1 ]
Anderson, Mary E. [2 ]
Lee, John H. [1 ,2 ]
机构
[1] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA
[2] Vet Hlth Adm, Dept Otolaryngol, US Dept Vet Affairs, Iowa City, IA USA
关键词
D O I
10.1001/archoto.2007.37
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To determine whether proteasome inhibition could reverse E6-mediated p53 degradation, cause selective growth inhibition, and induce apoptosis in human papillomavirus E6-transformed primary tonsil epithelial cells. Design: Primary human and mouse tonsil epithelial cell lines were transformed with a retrovirus containing human papillomavirus 16 oncogenes. MG132 was used to inhibit proteasome degradation in vitro and in vivo, and biochemical assays regarding p53 and apoptosis were performed. Results: In cells that express E6, proteasome inhibition with MG132 restored p53 protein levels and decreased proliferation in a dose-dependent fashion that was significantly more pronounced compared with controls. However, inhibition of proliferation occurred at a lower concentration than restoration of p53 protein expression. Also, wild-type and p53 knockout mouse tonsil epithelial cells that express E6 had near-identical inhibition of growth, suggesting that growth inhibition was p53 independent. In vivo studies did not demonstrate any growth inhibition. Conclusion: The findings suggest that proteasome inhibition preferentially inhibits proliferation in cells expressing E6 through a p53-independent mechanism.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [31] Inhibition of p53 degradation by Mdm2 acetylation
    Wang, XJ
    Taplick, J
    Geva, N
    Oren, M
    FEBS LETTERS, 2004, 561 (1-3): : 195 - 201
  • [32] Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms
    Onodera, H
    Nakamura, S
    Sugai, T
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1996, 18 (06) : 580 - 588
  • [33] Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
    Amjad Ali
    Zhuo Wang
    Junjiang Fu
    Lei Ji
    Jiang Liu
    Lei Li
    Hui Wang
    Jiwu Chen
    Carlos Caulin
    Jeffrey N. Myers
    Pei Zhang
    Jianru Xiao
    Bianhong Zhang
    Xiaotao Li
    Nature Communications, 4
  • [34] Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
    Ali, Amjad
    Wang, Zhuo
    Fu, Junjiang
    Ji, Lei
    Liu, Jiang
    Li, Lei
    Wang, Hui
    Chen, Jiwu
    Caulin, Carlos
    Myers, Jeffrey N.
    Zhang, Pei
    Xiao, Jianru
    Zhang, Bianhong
    Li, Xiaotao
    NATURE COMMUNICATIONS, 2013, 4
  • [35] Inhibition of proliferation by heparin and expression of p53 in cultured human vascular smooth muscle cells
    N Sawhney
    MK Patel
    M Schachter
    AD Hughes
    Journal of Human Hypertension, 1997, 11 : 611 - 614
  • [36] PADI/P53 signaling pathway was involved in the proliferation inhibition of SMMC-7721 cells
    Zhang, D.
    Sun, W.
    Du, P.
    Jiang, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1871 - 1871
  • [37] Inhibition of proliferation by heparin and expression of p53 in cultured human vascular smooth muscle cells
    Sawhney, N
    Patel, MK
    Schachter, M
    Hughes, AD
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (09) : 611 - 614
  • [38] Proteasome inhibition mediates p53 reactivation and anticancer activity of 6-Gingerol in cervical cancer cells
    Rastogi, Namrata
    Duggal, Shivali
    Singh, Shailendra Kumar
    Porwal, Konica
    Srivastava, Vikas Kumar
    Maurya, Rakesh
    Bhatt, Madan L. B.
    Mishra, Durga Prasad
    ONCOTARGET, 2015, 6 (41) : 43310 - 43325
  • [39] Mechanisms of p53 degradation
    Chao, Chuck C. -K.
    CLINICA CHIMICA ACTA, 2015, 438 : 139 - 147
  • [40] Mechanism of p53 degradation
    Brown, JP
    Pagano, M
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (02): : O1 - O6